E-Therapeutics PLC
OTC:ETXPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
E-Therapeutics PLC
OTC:ETXPF
|
UK |
|
N
|
Niraj Cement Structurals Ltd
NSE:NIRAJ
|
IN |
|
A
|
Austevoll Seafood ASA
SWB:Z85
|
NO |
|
Aduro Clean Technologies Inc
OTC:ACTHF
|
CA |
|
E
|
Eden Empire Inc
OTC:EDNEF
|
CA |
|
P
|
Phoenix Rising Companies
OTC:PRCX
|
MY |
|
I
|
Interstahl Handel Holding AG
XBER:LAH1
|
DE |
|
Rapid Dose Therapeutics Corp
OTC:RDTCF
|
CA |
|
Banyan Gold Corp
F:BAJ
|
CA |
|
R
|
Rekatech Capital Bhd
KLSE:REKATECH
|
MY |
|
Exel Industries SA
F:8YK
|
FR |
|
Xunlei Ltd
NASDAQ:XNET
|
CN |
Shareholder Yield
Current shareholder yield for 
ETXPF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ETXPF Price
E-Therapeutics PLC
| Average Annual Return | 14.1% |
| Standard Deviation of Annual Returns | 114.08% |
| Max Drawdown | -79% |
| Market Capitalization | 52.4m USD |
| Shares Outstanding | 584 334 976 |
| Percentage of Shares Shorted |
N/A
|
